Cleared Traditional

K884993 - VISUAL BLOOD GLUCOSE TEST SYSTEM

K884993 is the FDA 510(k) clearance for VISUAL BLOOD GLUCOSE TEST SYSTEM by Diagnostic Systems. It is a Class 2 Chemistry device (product code CGA) cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K884993 · Diagnostic Systems · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1988
Decision
28d
Days
Class 2
Risk

K884993 is an FDA 510(k) clearance for the VISUAL BLOOD GLUCOSE TEST SYSTEM. Classified as Glucose Oxidase, Glucose (product code CGA), Class II - Special Controls.

Submitted by Diagnostic Systems (Rock Hill, US). The FDA issued a Cleared decision on December 29, 1988 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Systems devices

Submission Details

510(k) Number K884993 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 01, 1988
Decision Date December 29, 1988
Days to Decision 28 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 88d · This submission: 28d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGA Glucose Oxidase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGA Glucose Oxidase, Glucose

All 197
Devices cleared under the same product code (CGA) and FDA review panel - the closest regulatory comparables to K884993.
GLUCOSE-SUPER FAST 4983050 AND 4983500
K882262 · American Research Products Co. · Feb 1989
CLINISTAT GLUCOSE REAGENT TEST
K884756 · Heraeus Kulzer, Inc. · Jan 1989
GLUCOSE LIQUID AMRESCO #4628300 & 4628001L
K884909 · American Research Products Co. · Jan 1989
ACCUCHEK II FREEDOM(TM) MONITORING SYSTEM
K883817 · Boehringer Mannheim Corp. · Dec 1988
TRACER(TM) II BLOOD GLUCOSE SYSTEM
K881908 · Boehringer Mannheim Corp. · Jul 1988
GLUCOSE (TRINDER) CAT. # 220-32
K875211 · Diagnostic Chemicals, Ltd. (Usa) · Apr 1988